Looking for optimal standards, criteria and KPIs of patient centricity across the biopharma industry: an overview of existing frameworks and conceptual models (Part 2)

Oleksandr Gorbenko, Merlin Williams


This work reflects the part 2 of our taskforce aimed to comprehensively analyse the selected 12 patient centricity frameworks/conceptual models and related key elements with the focus of their implementation potential and possible operational adoption by the biopharmaceutical industry.

Повний текст:

PDF (English)


Being Patient-Centric: An evidence-based self-evaluation toolkit for pharma… as recommended by patient groups. PatientView; November 2017.

CTTI Clinical Trial Transformation Initiative. CTTI recommendations: effective engagement with patient groups around clinical trials, October 2015. Access mode:

Deane K, Delbecque L, Gorbenko O, et al. Co-creation of patient engagement quality guidance for medicines development: an international multi-stakeholder initiative. BMJ Innovation 2019; 0:1–13.

FasteCures Value Framework: Integrating the Patient Perspective into the Development of Value Frameworks, March 2016. Access mode:

Managing Performance in Patient Centricity. Making the link between value for patients and value for the pharmaceutical industry. A Kinapse white paper; 2015:

National Health Council (NHC) Framework Dialogue / Advancing Meaningful Patient Engagement in Research, Development, and Review of Drugs, September 22, 2015. Access mode: files/PatientEngagement-WhitePaper.pdf.

National Standards for Public Involvement in Research. Multi-stakeholder group: INVOLVE, National Institute for Health Research, 2017; Access mode:

Patient Centricity Frameworks. A practitioner’s guide; Eyeforpharma, December 2017.

PCORI Funded Projects: Sample Engagement Plans From Methods Portfolio, August 6, 2014. Access mode:

PCORI Patient Engagement Rubric Engagement Rubric for Applicants, Feb 4, 2014 (updated June 6, 2016). Access mode:

People and Communities Board. Six principles for engaging people and communities: Definitions, evaluation and measurement. Published by the People and Communities Board, with support from National Voices, UK; June 2016; Access mode: measurement_-_web_high_res_0_1.pdf.

Perfetto et al. Framework: When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption, in Journal of Comparative Effectiveness Research, July 2013, Vol. 2, No. 4, Pages 383-391. Access mode:

Proctor E, Silmere H, Raghavan R, et al. Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda. Adm Policy Ment Health (2011) 38:65–76.

Taylor J. Oral presentation at the Patient Summit Europe 2018, session “Discover the organisational blueprint for scaling patient centricity” / Being Patient-Centric: A National Voices Perspective; 16 October, London;

University of Maryland M-CERSI Framework. Assessing meaningful patient engagement in drug development: a definition, framework, and rubric, March 2015. Access mode: wwwpharmacyumarylandedu/centers/cersievents/pfdd/mcersi-pfdd-framework-rubric.pdf.


  • Поки немає зовнішніх посилань.

Copyright (c) 2020 Oleksandr Gorbenko, Merlin Williams